The Difference in Carbon Footprint Between Diagnostic Upper GI Endoscopy in Dyspeptic Patients Versus Therapeutic Upper GI Bleeding
Recruiting
Observational Study
Carbon Footprint in Upper GI Endoscopy
Dyspepsia
Non-variceal Upper Gastrointestinal Bleeding
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 20 – 80
- Sex
- Any
- Study type
- Observational
- Participants needed
- 75 (estimated)
- Sponsor
- King Chulalongkorn Memorial Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this observational study is to learn about the carbon footprint produced from diagnostic upper GI endoscopy in patients with dyspepsia and therapeutic upper GI endoscopy in patients with non-variceal upper GI bleeding. The main question it aims to answer is:
• How much carbon footprint is generated from upper GI endoscopy Participants are already receiving diagnostic and therapeutic u…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with dyspepsia or non-variceal upper GI bleeding
* Age 20-80 years
* Body mass index of 30 or less;
* Receiving one of the following procedure during upper GI endoscopy:
For diagnostic endoscopy: Rapid urease test for H. pylori infection For therapeutic endoscopy: st…
Contacts